From March 2019 to September 2019, Dr. Toh worked with telemedicine companies to obtain access to Medicare and Medicaid patients and submitted more than $9.5 million in fraudulent claims for cancer genetic tests, according to a Sept. 5 news release from the Justice Department.
Dr. Toh, who is licensed in several states and operated as a consulting provider for telemedicine companies, signed the orders without regard to medical necessity, and he was not the treating physician of the patients.
He was indicted by a federal grand jury in December and convicted of conspiracy to violate the federal Anti-Kickback Statute after a two-week trial.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.